Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Erasca, Inc. (ERAS)

Erasca Q2 net loss widens to $44.1 million from $33.9 million a year earlier

Negative Impact 3 of 5 earnings Written later

Erasca reported a second-quarter 2026 net loss of $44.1 million, or $(0.14) per share, up from $33.9 million, or $(0.12) per share, a year earlier, as research and development spending rose. The company had $384.3 million in cash, cash equivalents, and marketable securities at June 30, 2026, and said a July 2026 public offering raised approximately $632.5 million in gross proceeds, which it expects will fund its listed milestones.

Key points

  • Net loss was $44.1 million, or $(0.14) per share, for the quarter ended June 30, 2026, versus $33.9 million, or $(0.12) per share, a year earlier.
  • R&D expenses were $35.9 million, up from $21.2 million, driven mainly by clinical trial and personnel costs.
  • Cash, cash equivalents, and marketable securities were $384.3 million at June 30, 2026, before the July offering of approximately $632.5 million in gross proceeds.

The filing

CompanyErasca, Inc. (ERAS)
Form8-K, current report
Filed with the SECAug 11, 2026, 4:05 PM ET
Accession number0001193125-26-344584

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:43 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 11, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.